Jan 1, 1989

The development and a clinical trial of an erythrocytic diagnostic agent for determining antibodies to the liver-specific lipoprotein

Laboratornoe delo
S V ZhavoronokA L Kalinin

Abstract

A simple method for the preparation of purified liver-specific protein has been developed and a sensitive and specific test-system has been created on its basis for the detection of antiLSP. The titres of antiLSP correlate with the activity of the pathological processes in patients with acute and chronic hepatitides. Immunosuppressive therapy results in elimination of antiLSP.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Hepatitis
Lipoproteins
Liver Dysfunction
Pathologic Processes
Cell Surface Proteins
Erythrocytes
Clinical Trial [Publication Type]
Hepatitis, Autoimmune
Liver
Surface Antigens

About this Paper

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.